SAN JOSE, Calif. — Takara Bio USA, Inc. today announced that it has once again prevailed in its second patent dispute with Jumpcode Genomics, Inc. The latest result concerns Takara Bio USA’s challenge to the validity of Jumpcode’s granted European patent EP3102722. Following a hearing before the Opposition Division of the European Patent Office on […]

Transformative New Operating Model to Feature Two Complementary Business Segments Aligned to Customer Needs: Laboratory Solutions and Bioscience Production  Company Launches Cost Optimization Initiative to Deliver $300M in Run Rate Savings by the end of 2026 Reaffirms Fiscal Year 2023 Guidance RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and […]

Biotage® PeptiPEC high-throughput kits facilitate fast and low solvent consumption solution for plate-based peptide purification Partnership complements Gyros’ PurePep® EasyClean technology offering with an automated solution for advanced discovery process Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, and Biotage, a global life sciences company, providing […]

MELBOURNE, Australia — IonOpticks, the world leader in high performance liquid chromatography for mass spectrometry, is proud to announce an exciting collaboration with Newomics Inc. that has produced an interface solution for their flagship Aurora Series columns and Agilent mass spectrometers. IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are […]

PALO ALTO, Calif.  – Bioz, Inc., a leading AI software company based in Silicon Valley, is thrilled to announce its partnership with Four E’s Scientific, a US-based leading provider of cutting-edge scientific equipment and solutions. With an impressive range of laboratory products, Four E’s Scientific has been providing laboratories around the world with quality instruments since […]

Supports ambitious commercialisation strategy for DNA synthesis platform, gSynth Follows $10m Series A financing to scale operations   Cambridge, UK: Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors. Following its $10 million Series A financing earlier in […]

The companies are working together on next-generation technology in the fast-growing field of synthetic biology. This new technology will improve the quality, speed, and cost of developing synthetic biological solutions such as life-saving vaccines, medicines, treatments, and therapies. Cambridge, UK  – EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, today […]

WASHINGTON, DC — Danaher Corporation (NYSE:DHR) (“Danaher”) announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) (“Abcam”). The acquisition of Abcam for $24.00 per share in cash was implemented by way of a Court-sanctioned scheme of arrangement under the UK Companies Act 2006 (the “Scheme”) and the Scheme became effective in accordance with its terms […]

● A reliable supply of consistent and physiologically relevant motor neurons is fundamental to the study and screening of potential treatments for motor neuron diseases (MNDs) ● ioMotor Neurons also offer an alternative to animals for neurotoxicity testing in the development of therapeutic products and consumer cosmetics procedures ● ioMotor Neurons are ready for experimentation […]

TOKYO – FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announces the investment of USD 200 million in two subsidiaries to significantly expand global cell therapy contract development and manufacturing (CDMO) capabilities. The investment will enable Fujifilm to support the expanding cell therapy market which is anticipated to grow by more than 30% per […]